These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9579843)

  • 1. Chromosomal imbalances in primary and metastatic pancreatic carcinoma as detected by interphase cytogenetics: basic findings and clinical aspects.
    Zojer N; Fiegl M; Müllauer L; Chott A; Roka S; Ackermann J; Raderer M; Kaufmann H; Reiner A; Huber H; Drach J
    Br J Cancer; 1998 Apr; 77(8):1337-42. PubMed ID: 9579843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interphase fluorescence in situ hybridization improves the detection of malignant cells in effusions from breast cancer patients.
    Zojer N; Fiegl M; Angerler J; Müllauer L; Gsur A; Roka S; Pecherstorfer M; Huber H; Drach J
    Br J Cancer; 1997; 75(3):403-7. PubMed ID: 9020486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
    Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
    Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.
    Jenkins RB; Qian J; Lieber MM; Bostwick DG
    Cancer Res; 1997 Feb; 57(3):524-31. PubMed ID: 9012485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA in situ hybridization (interphase cytogenetics) versus comparative genomic hybridization (CGH) in human cancer: detection of numerical and structural chromosome aberrations.
    Van Dekken H; Krijtenburg PJ; Alers JC
    Acta Histochem; 2000 Feb; 102(1):85-94. PubMed ID: 10726167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of myc and chromosome 8 copy number in colorectal cancer using interphase cytogenetics.
    Obara K; Yokoyama M; Asano G; Tanaka S
    Int J Oncol; 2001 Feb; 18(2):233-9. PubMed ID: 11172587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Numerical aberrations of chromosomes 1 and 7 in renal cell carcinomas as detected by interphase cytogenetics.
    Beck JL; Hopman AH; Feitz WF; Schalken J; Schaafsma HE; Van de Kaa CA; Ramaekers FC; Hanselaar AG; De Wilde PC
    J Pathol; 1995 Jun; 176(2):123-35. PubMed ID: 7636622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperdiploidy and apparent aneusomy in mesothelial cells from non-malignant effusions as detected by fluorescence in situ hybridization (FISH).
    Fiegl M; Zojer N; Kaufmann H; Müllauer L; Schuster R; Huber H; Drach J
    Cytometry; 1999 Feb; 38(1):15-23. PubMed ID: 10088972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization.
    Parrella P; Caballero OL; Sidransky D; Merbs SL
    Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1679-84. PubMed ID: 11431428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of fluorescence in situ hybridization in pancreatic ductal adenocarcinoma.
    Adsay NV; Dergham ST; Koppitch FC; Dugan MC; Mohamed AN; Vaitkevicius VK; Sarkar FH
    Pancreas; 1999 Mar; 18(2):111-6. PubMed ID: 10090407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aneuploidy of chromosome 8 as detected by interphase fluorescence in situ hybridization is a recurrent finding in primary and metastatic breast cancer.
    Roka S; Fiegl M; Zojer N; Filipits M; Schuster R; Steiner B; Jakesz R; Huber H; Drach J
    Breast Cancer Res Treat; 1998 Mar; 48(2):125-33. PubMed ID: 9596484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interphase fluorescence in situ hybridization analysis: a study using centromeric probes 7, 8, and 12.
    Zhao L; Khan Z; Hayes KJ; Glassman AB
    Ann Clin Lab Sci; 1998; 28(1):51-6. PubMed ID: 9512785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization.
    Qian J; Jenkins RB; Bostwick DG
    Mod Pathol; 1997 Nov; 10(11):1113-9. PubMed ID: 9388062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interphase cytogenetics in oncocytic adenomas and carcinomas of the thyroid gland.
    Mazzucchelli L; Burckhardt E; Hirsiger H; Kappeler A; Laissue JA
    Hum Pathol; 2000 Jul; 31(7):854-9. PubMed ID: 10923924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of chromosomal aneuploidy by interphase fluorescence in situ hybridization in bronchoscopically gained cells from lung cancer patients.
    Schenk T; Ackermann J; Brunner C; Schenk P; Zojer N; Roka S; Drach J
    Chest; 1997 Jun; 111(6):1691-6. PubMed ID: 9187195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant cell detection by fluorescence in situ hybridization (FISH) in effusions from patients with carcinoma.
    Fiegl M; Kaufmann H; Zojer N; Schuster R; Wiener H; Müllauer L; Roka S; Huber H; Drach J
    Hum Pathol; 2000 Apr; 31(4):448-55. PubMed ID: 10821492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple myeloma: high incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization.
    Drach J; Schuster J; Nowotny H; Angerler J; Rosenthal F; Fiegl M; Rothermundt C; Gsur A; Jäger U; Heinz R
    Cancer Res; 1995 Sep; 55(17):3854-9. PubMed ID: 7641204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis.
    Murphy DS; Hoare SF; Going JJ; Mallon EE; George WD; Kaye SB; Brown R; Black DM; Keith WN
    J Natl Cancer Inst; 1995 Nov; 87(22):1694-704. PubMed ID: 7473818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interphase cytogenetics reveals a high incidence of aneuploidy and intra-tumour heterogeneity in breast cancer.
    Fiegl M; Tueni C; Schenk T; Jakesz R; Gnant M; Reiner A; Rudas M; Pirc-Danoewinata H; Marosi C; Huber H
    Br J Cancer; 1995 Jul; 72(1):51-5. PubMed ID: 7599066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of MYC and chromosome 8 copy number in breast carcinoma by interphase cytogenetics.
    Visscher DW; Wallis T; Awussah S; Mohamed A; Crissman JD
    Genes Chromosomes Cancer; 1997 Jan; 18(1):1-7. PubMed ID: 8993975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.